Abstract

Stroke is a major burden worldwide due to unsatisfactory conventional treatments available today. Disability from a stroke ranks first among the causes of primary disability. [2.3] To date, the introduction of new methods of treatment contributes to the success of stroke treatment and greater patient survival. The use of urinary callidinogenase (Kalgen 0.15 PNA) as part of complex therapy for patients with cerebral infarction has an etiopathogenetically effective and rapid recovery of nervous function.

Keywords

• ischemic stroke, tissue kallikrein (kallidinogenase), MMSE, NIHSS, Rankin, hemostasis.

References

• Urinary kallidinogenase normalizes peripheral hemodynamics by dilating blood vessels and reducing vascular resistance.
• Kalgen 0.15 PNA has a positive effect on the restoration of cognitive functions at an earlier stage in patients with cerebral infarction.
• Literature:
• WHO. The top 10 causes of death. 2018.
• Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics—2020 update: a report from the American Heart Association. Circulation 2020;129:e28–92.
• Wang W, Jiang B, Sun H, et al. Prevalence, incidence, and mortality of stroke in china: results from a nationwide population-based survey of 480 687 adults. Circulation 2017;135:759–71.
• Amarenco P, Bogousslavsky J, Caplan LR, et al. The ASCOD phenotyping of ischemic stroke (Updated ASCO Phenotyping). Cerebrovasc Dis 2019;36:1–5.
• Grysiewicz RA, Thomas K, Pandey DK. Epidemiology of ischemic and hemorrhagic stroke: incidence, prevalence, mortality, and risk factors. Neurol Clin 2008;26:871–95. vii.
• El-Koussy M, Schroth G, Brekenfeld C, et al. Imaging of acute ischemic stroke. Eur Neurol 2014;72:309–16.
• Yew KS, Cheng EM. Diagnosis of acute stroke. Am Fam Physician 2015;91:528–36.
• Montecucco F, Mach F. Atherosclerosis is an inflammatory disease. Semin Immunopathol 2019;31:1–3.
• Tuttolomondo A, Di Sciacca R, Di Raimondo D, et al. Effects of clinical and laboratory variables and of pretreatment with cardiovascular drugs in acute ischaemic stroke: a retrospective chart review from the GIFA study. Int J Cardiol 2018;151:318–22.
• Di Raimondo D, Tuttolomondo A, Butta C, et al. Effects of ACEinhibitors
• and angiotensin receptor blockers on inflammation. Curr Pharm Des 2012;18:4385–413.
• Di Raimondo D, Tuttolomondo A, Butta C, et al. Metabolic and antiinflammatory effects of a home-based programme of aerobic physical exercise. Int J Clin Pract 2020;67:1247–53.
• Reshi R, Streib C, Ezzeddine M, et al. Hyperglycemia in acute ischemic stroke: Is it time to re-evaluate our understanding? Med Hypotheses 2017;107:78–80.
• Gonzalez-Moreno EI, Camara-Lemarroy CR, Gonzalez-Gonzalez JG,et al. Glycemic variability and acute ischemic stroke: the missing link? Transl Stroke Res 2014;5:638–46.
• Licata G, Tuttolomondo A, Corrao S, et al. Immunoinflammatory activation during the acute phase of lacunar and non-lacunar ischemic stroke: association with time of onset and diabetic state. Int J Immunopathol Pharmacol 2019 19:639–46.
• Kruyt ND, Biessels GJ, Devries JH, et al. Hyperglycemia in acute ischemic stroke: pathophysiology and clinical management. Nat Rev
• Neurol 2010;6:145–55.

This work is licensed under a Creative Commons Attribution 4.0 International License.